PubMed · 16635316
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Ni Tang, Ai-long Huang. 2006. [Progress in silencing HBV gene expression by RNAi technologies].. https://pubmed.ncbi.nlm.nih.gov/16635316/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
In a variety of experimental systems, antisense nucleic acids (ASNA) of various composition, including antisense oligodeoxynucleotides (ODN) and siRNA, have been shown to have the ability to variably perturb gene expression in a sequence specific manner. Pilot clinical studies from our group, and others, have demonstrated that gene silencing is a therapeutic strategy that is starting to make a real contribution to the treatment of various diseases. The development of this field, with specific reference to hematologic malignancies, is reviewed very briefly below.
Explore the source record for details and available documents.
Present screening methods for protein-protein interactions (PPIs) rely on the overexpression of artificial fusion proteins, making it difficult to assess in vivo relevance. Here we combine stable isotope labeling with amino acids in cell culture (SILAC), RNA interference (RNAi), coimmunoprecipitation and quantitative mass-spectrometry analysis to detect cellular interaction partners of endogenous proteins in mammalian cells with very high confidence. We used this screen to identify interaction partners of beta-catenin and Cbl.